多参数MRI引导下对CT为基础的高剂量率前列腺近距离放疗中优势前列腺内病灶进行剂量推量
本研究回顾性分析17例接受高剂量率前列腺近距离放疗患者的21个多参数MRI定义的优势前列腺内病灶,通过MR/CT配准将DIL轮廓传播至CT图像并优化推量计划。结果显示优化推量计划可在满足危及器官约束下显著提高DIL剂量,虚拟植入针可使85%的DIL达到V150>90%(无额外针时为57%),TCP模型估计外照射患者DIL控制率提高28%、单药治疗患者提高8%。结论认为该策略可行且可能改善肿瘤控制。
要点
- 多参数MRI定义的DIL可通过变形配准传播至CT图像用于HDR近距离放疗推量计划。
- 优化推量计划可在满足OAR约束下显著提高DIL剂量覆盖。
- 虚拟植入mp-MRI引导针可使85%的DIL达到V150>90%,而无额外针时为57%。
核心结论
- 基于MR/CT配准的mp-MRI引导DIL推量在CT为基础的高剂量率前列腺近距离放疗中可行且不违反OAR约束。
- TCP模型估计该推量可改善DIL的肿瘤控制概率,外照射治疗患者提高28%,单药治疗患者提高8%。
- 作者认为该策略可能代表个体化治疗实施并改善肿瘤控制的方法。
研究设计与样本
- 回顾性研究,共纳入17例患者,21个DIL,均有治疗前mp-MRI和CT图像并接受HDR前列腺近距离放疗。
- DIL在mp-MRI上勾画,通过变形图像配准方法传播至CT图像。
- 为每位患者创建推量计划并在原始针道模式上优化;另使用虚拟植入DIL周围针道模拟mp-MRI引导针放置生成单独计划。
- 比较DIL剂量覆盖和OAR保护与原始计划结果,并估计TCP以评估推量计划的临床影响。
诊断标准与关键数值
- 优化推量计划显著提高DIL剂量同时满足OAR约束。
- 添加mp-MRI引导虚拟针后,85%的DIL达到V150>90%,而无额外针的推量计划为57%。
- TCP模型估计相比原始计划,外照射治疗患者DIL控制改善28%,单药治疗患者改善8%。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to investigate the dosimetric feasibility of delivering focal dose to multiparametric (mp) MRI-defined DILs in CT-based high-dose-rate (HDR) prostate brachytherapy with MR/CT registration and estimate its clinical benefit.
METHODS: We retrospectively investigated a total of 17 patients with mp-MRI and CT images acquired pre-treatment and treated by HDR prostate brachytherapy. 21 dominant intraprostatic lesions (DILs) were contoured on mp-MRI and propagated to CT images using a deformable image registration method. A boost plan was created for each patient and optimized on the original needle pattern. In addition, separate plans were generated using a virtually implanted needle around the DIL to mimic mp-MRI guided needle placement. DIL dose coverage and organ-at-rick (OAR) sparing were compared with original plan results. Tumor control probability (TCP) was estimated to further evaluate the clinical impact on the boost plans.
RESULTS: Overall, optimized boost plans significantly escalated dose to DILs while meeting OAR constraints. The addition of mp-MRI guided virtual needles facilitate increased coverage of DIL volumes, achieving a V150 > 90% in 85 % of DILs compared with 57 % of boost plan without an additional needle. Compared with original plan, TCP models estimated improvement in DIL control by 28 % for patients with external-beam treatment and by 8 % for monotherapy patients.
CONCLUSION: With MR/CT registration, the proposed mp-MRI guided DIL boost in CT-based HDR brachytherapy is feasible without violating OAR constraints, and indicates significant clinical benefit in improving TCP of DIL. It may represent a strategy to personalize treatment delivery and improve tumor control.
ADVANCES IN KNOWLEDGE: This study investigated the feasibility of mp-MRI guided DIL boost in HDR prostate brachytherapy with CT-based treatment planning, and estimated its clinical impact by TCP and NTCP estimation.
引用
- Wang T, Press RH, Giles M, et al. Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy. Br J Radiol. 2019. PMID: 30912959. doi:10.1259/bjr.20190089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。